Synopsys: Performance reviews feel unusually harsh this cycle

Has anyone else noticed the performance reviews at Synopsys feeling a lot more critical this year? Usually, it's a pretty standard process, but this time around, it feels like everyone is getting marked down for minor things, or the bar has been significantly raised without much warning. Some of my colleagues who consistently hit their targets are being told they 'could have done more' or that their contributions weren't 'impactful enough.' It's creating a lot of anxiety, and frankly, it feels like a precursor to something. With the general market uncertainty, I can't help but wonder if this is the company's way of building a case for future reductions, or perhaps setting the stage for a more aggressive PIP process. Anyone else experiencing this, or am I just being overly paranoid?